Co-Authors
This is a "connection" page, showing publications co-authored by France Mentré and Olivier Epaulard.
Connection Strength
0.118
-
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-ß-1a and hydroxychloroquine in hospitalized patients with COVID-19. Clin Microbiol Infect. 2021 Dec; 27(12):1826-1837.
Score: 0.059
-
Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort. Clin Microbiol Infect. 2021 Jul; 27(7):1041.e1-1041.e4.
Score: 0.059